Tumor tissue CA125 in ovarian carcinoma patients with normal serum levels

被引:4
|
作者
Menczer, J
Zakut, H
Schejter, E
Ginath, S
Tell, L
Zajdel, L
机构
[1] EDITH WOLFSON MED CTR,DEPT PATHOL,IL-58100 HOLON,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
关键词
ovarian carcinoma; serum CA125; tissue CA125;
D O I
10.1046/j.1525-1438.1997.00459.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A good correlation between elevated serum CA125 and its immunolocalization in ovarian tumor tissue has been reported. This study was undertaken in order to assess the presence of CA125 in tumor tissue obtained from ovarian carcinoma patients with normal serum levels. Eleven such ovarian carcinoma patients (nine of them serous) were identified. In seven the level was normal prior to the initial operation, and in four, prior to a positive second-look operation. Immunohistochemical staining of paraffin sections for CA125 was positive in seven of the tumor tissue samples. Tumor tissue of most ovarian carcinoma patients with a preoperative normal serum CA125 contains the antigen, but an undetermined mechanism prevents elevated serum levels.
引用
收藏
页码:304 / 306
页数:3
相关论文
共 50 条
  • [41] Ovarian vein vs peripheral blood CA125 serum levels: A comparative study
    Podnos, YD
    Gamboa, G
    Kurosaki, T
    Buller, R
    Walker, JL
    Manetta, A
    GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 71 - 74
  • [42] High grade, advanced, serous ovarian cancer with low serum CA125 levels
    Asali, Aula
    Haj-Yehia, Nasreen
    Zehavi, Tania
    Perry, Talila
    Beiner, Mario
    Fishman, Ami
    Kadan, Yfat
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (07) : 1107 - 1111
  • [43] Benign ovarian fibroma with ascites and high serum levels of CA125:: a case report
    Shabani, N.
    Puchner, T.
    W, Schuetze
    Jeschke, U.
    Mylonas, I
    Friese, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 532 - 532
  • [44] COMBINED ASSAY OF SERUM LEVELS OF CA125 AND CA19-9 IN ENDOMETRIAL CARCINOMA
    TAKESHIMA, N
    SHIMIZU, Y
    UMEZAWA, S
    HIRAI, Y
    CHEN, JT
    FUJIMOTO, I
    YAMAUCHI, K
    HASUMI, K
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 321 - 326
  • [45] ELEVATED CA125 LEVELS IN PATIENTS WITH METASTATIC BREAST-CARCINOMA
    PEREY, L
    HAYES, DF
    TONDINI, C
    VANMELLE, G
    BAUER, J
    LEMARCHAND, T
    REYMOND, M
    MACH, JP
    LEYVRAZ, S
    BRITISH JOURNAL OF CANCER, 1990, 62 (04) : 668 - 670
  • [46] THE PROGNOSTIC VALUE OF EARLY CA125 SERUM ASSAY IN EPITHELIAL OVARIAN-CARCINOMA
    FISKEN, J
    LEONARD, RCF
    STEWART, M
    BEATTIE, GJ
    STURGEON, C
    ASPINALL, L
    ROULSTON, JE
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 140 - 145
  • [47] Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage
    Fures, R
    Bukovic, D
    Hodek, B
    Klaric, P
    Herman, R
    Grubisic, G
    COLLEGIUM ANTROPOLOGICUM, 1999, 23 (01) : 189 - 194
  • [48] CA-125 AND MAM-6 IN SERUM AND TUMOR OF PATIENTS WITH OVARIAN-CARCINOMA
    KOLDOVSKY, U
    WARGALLA, U
    HILKENS, J
    FELDHAMMER, B
    KROIZIN, S
    BROSS, M
    HILGERS, J
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (03) : 125 - 128
  • [49] The predictive and prognostic value of serum CA125 kinetics and CA125 nadir during paclitaxel/platinum based chemotherapy (QT) in patients with advanced ovarian carcinoma (OC)
    Tibau, A.
    Ojeda, M. B.
    Nadal, R. M.
    Gallardo, A.
    Perez Altozano, J.
    Sala, N.
    Mazarico, J. M.
    Boguna, I.
    Artigas, V.
    Barnadas, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 457 - 457
  • [50] STUDY ON CA125 IN OVARIAN AND BREAST-CARCINOMA - CORRELATION OF THE SERUM LEVELS OF THIS MARKER WITH THOSE OF CEA, TPA, AND FERRITIN
    ESPOSITO, G
    IANNACCONE, D
    MAFFEO, A
    DAIUTO, G
    PICCININNI, L
    DEMATTEIS, A
    LAPENTA, L
    BAZZICALUPO, L
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1985, 29 (1-2): : 71 - 72